Target engagement of the subgenual anterior cingulate cortex with transcranial temporal interference stimulation in major depressive disorder: a protocol for a randomized sham-controlled trial
National Alliance for Research on Schizophrenia and Depression
Royal College of Physicians and Surgeons of Canada
Government of Canada
Associated Medical Services
University of Toronto
Eisai
Servier
H. Lundbeck A/S
Ministère de la Défense Nationale
Allergan
Canadian Institutes of Health Research
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article
Target engagement of the subgenual anterior cingulate cortex with transcranial temporal interference stimulation in major depressive disorder: a protocol for a randomized sham-controlled trial
Emiliano Santarnecchi, John D. Griffiths, Abhishek Datta, Nathan W. Churchill et al.
Citations
14 citations
Journal
Frontiers in Neuroscience
Topics
Transcranial Magnetic Stimulation Studies
Field-Weighted Citation Impact (FWCI)
3.46
article
Target engagement of the subgenual anterior cingulate cortex with transcranial temporal interference stimulation in major depressive disorder: a protocol for a randomized sham-controlled trial
Emiliano Santarnecchi, John D. Griffiths, Abhishek Datta, Nathan W. Churchill, Tom A. Schweizer, Sidney H. Kennedy, Alice Rueda, Venkat Bhat, Sumientra Rampersad, Ilya Demchenko, Sridhar Krishnan, Edward S. Boyden, Andreas Horn
article en
14 citations
Abstract
No abstract available for this paper.
Publication Tag
Frontiers in NeuroscienceVol. 18
Institutions
City College of New York (US), Brigham and Women's Hospital (US), Northeastern University (US), St. Michael's Hospital (CA), Centre for Addiction and Mental Health (CA), Howard Hughes Medical Institute (US), Harvard University (US), McGovern Institute for Brain Research (US), University of Toronto (CA), University of Massachusetts Boston (US), Humboldt-Universität zu Berlin (DE), Gordon Center for Medical Imaging (US), Massachusetts General Hospital (US), Soterix Medical (United States) (US), Circuit Therapeutics (United States) (US), Center for Neuro-Oncology (US), Unity Health Toronto, Toronto Metropolitan University (CA), Massachusetts Institute of Technology (US), Freie Universität Berlin (DE), Charité - Universitätsmedizin Berlin (DE)
Funders
Brain and Behavior Research Foundation, American Foundation for Suicide Prevention, Pfizer, Boston Scientific Corporation, Fondation Brain Canada, Sunovion, National Alliance for Research on Schizophrenia and Depression, Royal College of Physicians and Surgeons of Canada, Government of Canada, Associated Medical Services, University of Toronto, Eisai, Servier, H. Lundbeck A/S, Ministère de la Défense Nationale, Allergan, Canadian Institutes of Health Research